[Prevention of agranulocytosis during treatment with pyrazolone derivatives, especially with aminophenazone (Pyramidon)].
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced / Q000517:prevention & control*; D000632:Aminopyrine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D012216:Rheumatic Diseases / Q000188:drug therapy
D000632:Aminopyrine
Preventie van agranulocytose tijdens het gebruik van pyrazolon-derivaten , in het bijzonder van aminofenazon (Pyramidon.